Japan Lifeline Co., Ltd. announced that at the board of directors meeting held today, it has decided to make the following changes to its personnel.
1. Changes in personnel (Effective on July 1, 2023)
New position and title
Name
Old position and title
Deputy General Manager of Oyama
Manager of Oyama Quality Assurance
Factory of R&D and Manufacturing
Naoyasu Shibano
Section of Quality Assurance Division of
Headquarters
R&D & Manufacturing Headquarters
General Manager of Ichihara Factory of
Ichihara R&D & Manufacturing
Naoki Nishiguchi
General Manager of Oyama Factory of
Department of R&D and Manufacturing
R&D and Manufacturing Headquarters
Headquarters
Attachments
Original Link
Original Document
Permalink
Disclaimer
JLL - Japan Lifeline Co. Ltd. published this content on 23 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 23 May 2023 06:49:06 UTC.
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.